Recombinant antigen EBNA1 for Epstein-barr virus (EBV)

Epstein-barr virus (EBV)

EBNA1 has a predominant role in the maintenance of latent EBV infections and is expressed in all EBV infections and all EBV-associated malignant tissues. It contains a Gly-Ala repeated domain flanked by two unique regions. The central , C-terminus and N-terminus regions have been described as potentially antigenic.

More information about Epstein-Barr virus infection (EBV).

or
Name
EBNA1
Description
Late nuclear antigen
Gene
BKRF1
Purity
> 95% by observation on SDS-PAGE electrophoresis
References
SKU Source Applications In-house validation Details
RAG0007 E. coli WB, DB, IE, DE, CLIA, LF ELISA Example of a certificate of analysis Material Safety Data Sheet
RAG0047 Top product (Satisfaction guarantee) E. coli WB, DB, IE, DE ELISA Example of a certificate of analysis Material Safety Data Sheet
WB: Western Blot | DB: Dot Blot | IE: Indirect ELISA | DE: positive control in Direct ELISA | CLIA: Chemiluminescent immunoassay | LF: Lateral-Flow | CE: Capture ELISA | DAS: Double Antigen Sandwich ELISA | NP: Nanoparticles binding | PO: Plate orientation | COA: Certificate of analysis | SDS: Material Safety Data Sheet
Top product (Satisfaction guarantee) Top product (Satisfaction guarantee)
Formats
Liquid solution or dry powder (lyophilised) in vials of 0.1 mg, 1 mg and bulk
Related products

For research and comercial use IVD only (*)

(*) Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use. You can get more information about the general features and about the shipping, storage, defrost, manipulation and stability of all of our reagents. In addition, we follow a rigorous quality control for each lot.

Bact to list of Proteins for human infectious diseases